Literature DB >> 22307090

In vitro modulatory effects of flavonoids on human cytochrome P450 2C8 (CYP2C8).

Chia Yong Pang1, Joon Wah Mak, Rusli Ismail, Chin Eng Ong.   

Abstract

The inhibitory effects of five flavonoids with distinct chemical classes (flavones [luteolin], flavonols [quercetin and quercitrin], and flavanones [hesperetin and hespiridin]) on cDNA-expressed CYP2C8 were investigated. CYP2C8 was co-expressed with NADPH-cytochrome P450 reductase in Escherichia coli and used to characterise potency and mechanism of these flavonoids on the isoform. Tolbutamide 4-methylhydroxylase, a high-performance liquid chromatography-based assay, was selected as marker activity for CYP2C8. Our results indicated that the flavonoids inhibited CYP2C8 with different potency. The order of inhibitory activities was quercetin > luteolin > hesperetin > hesperidin > quercitrin. All of these compounds however exhibited mechanism-based inhibition. A number of structural factors were found to be important for inhibition; these include the molecular shape (volume to surface ratio), the number of hydroxyl groups as well as glycosylation of the hydroxyl group. Quercetin was the most potent inhibitor among the flavonoids examined in this study, and our data suggest that it should be examined for potential pharmacokinetic drug interactions pertaining to CYP2C8 substrates in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307090     DOI: 10.1007/s00210-012-0731-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research.

Authors:  C M Masimirembwa; C Otter; M Berg; M Jönsson; B Leidvik; E Jonsson; T Johansson; A Bäckman; A Edlund; T B Andersson
Journal:  Drug Metab Dispos       Date:  1999-10       Impact factor: 3.922

2.  In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids.

Authors:  F P Guengerich; D H Kim
Journal:  Carcinogenesis       Date:  1990-12       Impact factor: 4.944

3.  Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.

Authors:  Xue-Qing Li; Anders Björkman; Tommy B Andersson; Marianne Ridderström; Collen M Masimirembwa
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

Review 4.  Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance.

Authors:  Rheem A Totah; Allan E Rettie
Journal:  Clin Pharmacol Ther       Date:  2005-05       Impact factor: 6.875

5.  Absorption, metabolism and health effects of dietary flavonoids in man.

Authors:  P C Hollman; M B Katan
Journal:  Biomed Pharmacother       Date:  1997       Impact factor: 6.529

6.  In vitro modulation of naturally occurring flavonoids on cytochrome P450 2A6 (CYP2A6) activity.

Authors:  K H Tiong; B C Yiap; E L Tan; R Ismail; C E Ong
Journal:  Xenobiotica       Date:  2010-07       Impact factor: 1.908

7.  Structure-related inhibition of human hepatic caffeine N3-demethylation by naturally occurring flavonoids.

Authors:  H Lee; H Yeom; Y G Kim; C N Yoon; C Jin; J S Choi; B R Kim; D H Kim
Journal:  Biochem Pharmacol       Date:  1998-05-01       Impact factor: 5.858

8.  Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.

Authors:  S J Baldwin; S E Clarke; R J Chenery
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

9.  Functional role of Ile264 in CYP2C8: mutations affect haem incorporation and catalytic activity.

Authors:  Rajinder Singh; Jonathan G Ting; Yan Pan; Lay Kek Teh; Rusli Ismail; Chin Eng Ong
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

10.  Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.

Authors:  A Rahman; K R Korzekwa; J Grogan; F J Gonzalez; J W Harris
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

View more
  5 in total

1.  Publication trends in Naunyn-Schmiedeberg's Archives of Pharmacology: focus on pharmacology in Egypt.

Authors:  Mahmoud M El-Mas; Hanan M El-Gowelli; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-14       Impact factor: 3.000

2.  AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.

Authors:  Ju-Hyun Kim; Soon-Sang Kwon; Tae Yeon Kong; Jae Chul Cheong; Hee Seung Kim; Moon Kyo In; Hye Suk Lee
Journal:  Molecules       Date:  2017-03-10       Impact factor: 4.411

3.  The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity.

Authors:  Mirza Bojić; Martin Kondža; Hrvoje Rimac; Goran Benković; Željan Maleš
Journal:  Molecules       Date:  2019-09-01       Impact factor: 4.411

4.  Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles.

Authors:  Shun-Bin Luo; Er-Min Gu; Yu-Ao Chen; Shi-Chen Zhou; Chen Fan; Ren-Ai Xu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

Review 5.  Nutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatment.

Authors:  Christian Leischner; Markus Burkard; Matthias M Pfeiffer; Ulrich M Lauer; Christian Busch; Sascha Venturelli
Journal:  Nutr J       Date:  2016-05-04       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.